The on-schedule acceptance underscores the Company's disciplined execution of its clinical and regulatory strategy...
The three-day exhibition in northeast China covers medical imaging, in vitro diagnostics, surgical systems, AI healthcare, telemedicine, robotics and hospital infrastructure....
The 360-patient study showed statistically significant improvement in 90-day functional outcomes, with no investigational drug-related serious adverse events reported....
Harnessing dual-device synergies, multi-energy technologies, and pioneering layered protocols, Sisram cements its strategic leadership across APAC...
Fosun International expects first-half profit to rise by 127% to 172%, supported by its core businesses as Fosun Pharma records new drug and clinical trial application progress....
The upgraded service system is designed around risk prevention and proactive intervention, supporting a shift from traditional reactive healthcare towards preventive and personalised health management...
The advancement of ADC 2.0 candidates AK146D1 and AK138D1 into Phase II trials marks a critical milestone for Akeso's "IO2.0 + ADC2.0" strategy...
The city is also home to over 1,500 venture capital funds managing more than $200 billion in assets...
The China-developed surgical robot supported a total knee replacement in a Brazilian public hospital, demonstrating its open-platform compatibility with local prosthesis systems. ...
At ERA 2026, the company will showcase the next generation of dialysis and CRRT platforms designed to support intelligent automation, connected care, workflow efficiency, and integrated therapy delivery...
